Statins may improve tolerability of antidepressant therapy
1. In a large population-based cohort study, combination therapy of antidepressant therapy with a...
Read MoreNov 18, 2023
1. In a large population-based cohort study, combination therapy of antidepressant therapy with a...
Read MoreNov 16, 2023
1. In this randomized controlled trial, patients with polymyalgia rheumatica (PMR) flares who...
Read MoreNov 16, 2023
1. Redo-TAVR had low procedural complication rates and was comparable to native-TAVR in terms of...
Read MoreNov 15, 2023
Bookmark1. In this meta-analysis, both high-intensity interval training and moderate-intensity...
Read MoreNov 15, 2023
Bookmark1. In this randomized controlled trial, compared to placebo, dexamethasone did not improve...
Read MoreNov 15, 2023
Bookmark1. In this randomized controlled trial, percutaneous coronary intervention (PCI) performed...
Read MoreNov 15, 2023
Bookmark1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading...
Read MoreNov 14, 2023
Bookmark1. A greater percentage of patients who received concurrent stereotactic radiation therapy...
Read MoreNov 14, 2023
Bookmark1. Progression-free survival was 6.3 months for the amivantamab–chemotherapy group, 8.3...
Read MoreNov 14, 2023
Bookmark1. In this randomized controlled trial, in patients with treatment-resistant depression...
Read MoreNov 14, 2023
Bookmark1. In this randomized controlled trial, tight versus liberal blood glucose control...
Read MoreNov 11, 2023
Bookmark1. In this randomized controlled trial, in patients with heart failure with preserved...
Read MoreNov 10, 2023
Bookmark1. In this randomized controlled trial, over a period of 240 weeks, solanezumab did not...
Read MoreNov 9, 2023
Bookmark1. Total knee arthroplasty was found to decrease the incidence of depression among...
Read MoreNov 9, 2023
Bookmark1. Median overall survival increased by 3.2 months in the sacituzumab govitecan group...
Read MoreNov 8, 2023
Bookmark1. In this cross-sectional study, spiritual intelligence was a significant predictor of...
Read MoreNov 8, 2023
Bookmark1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative...
Read MoreNov 8, 2023
Bookmark1. This cross-sectional study found that physical activity, employment, pain, and sense of...
Read MoreNov 7, 2023
Bookmark1. The progression-free survival was 24.8 months in the selpercatinib group vs 11.2 months in the control group (chemotherapy ± pembrolizumab), with an HR of 0.46. 2. Grade ≥3 adverse events occurred in 70% vs 57%...
Read MoreNov 1, 2023
Bookmark1. 30-day mortality was comparable among patients on VA-ECMO and medical therapy alone. 2....
Read More